Which GLP-1 causes the most weight loss?
Mounjaro (tirzepatide) produces the highest average weight loss at around 22% of body weight in clinical trials. Wegovy (semaglutide 2.4mg) comes second at around 15%. Both significantly outperform older GLP-1 medications like Saxenda and Victoza.
What is the difference between Ozempic and Wegovy?
Both contain semaglutide, but at different doses. Ozempic is licensed for type 2 diabetes at up to 2mg weekly. Wegovy is licensed specifically for weight loss at up to 2.4mg weekly. Wegovy produces greater weight loss because of the higher dose, but is more expensive. Many UK clinics prescribe Ozempic off-label for weight loss at lower cost.
Can I get GLP-1 medication on the NHS?
Yes, but access is restricted. Wegovy and Saxenda are available via NHS specialist weight management services for patients with a BMI over 35 plus a weight-related condition, or BMI over 40. Waiting lists are long. Most people access GLP-1 medications privately through online clinics in 1-2 weeks.
How much does GLP-1 medication cost privately in the UK?
Private GLP-1 costs range from around £80-£150 per month for Ozempic to £149-£299 per month for Wegovy and Mounjaro depending on the clinic and dose. Most clinics include online doctor consultations in the price. Compare clinics carefully as monitoring quality varies significantly.
Is there an oral GLP-1 medication available in the UK?
Rybelsus (oral semaglutide) is available in the UK and licensed for type 2 diabetes. It produces slightly less weight loss than injectable semaglutide because oral absorption is lower. Oral tirzepatide is in late-stage trials. See our full guide to oral GLP-1 options.